Jones Financial Companies
ALNY icon

Jones Financial Companies’s Alnylam Pharmaceuticals ALNY Stock Holding History

Jones Financial Companies’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23.5M Buy
80,491
+6,848
+9% +$2.07M 0.01% 628
2026
Q1 		$23.4M Buy
73,643
+72,863
+9,341% +$24.8M 0.01% 540
2025
Q4 		$310K Buy
780
+238
+44% +$105K ﹤0.01% 1716
2025
Q3 		$242K Sell
542
-30
-5% -$12.2K ﹤0.01% 1714
2025
Q2 		$185K Buy
572
+153
+37% +$42.3K ﹤0.01% 1691
2025
Q1 		$112K Buy
419
+153
+58% +$39.3K ﹤0.01% 1722
2024
Q4 		$62.6K Buy
+266
New +$70K ﹤0.01% 1792
2023
Q1 		– Sell
-4
Closed -$1K – 573
2022
Q4 		$1K Buy
+4
New +$853 ﹤0.01% 629

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jones Financial Companies's ALNY Position: Q2 2026 in Review

Jones Financial Companies increased its Alnylam Pharmaceuticals (ALNY) stake by 9.3% in Q2 2026, buying an estimated $2.07M and bringing the position to 80,491 shares worth $23.5M. The position accounts for 0.01% of the portfolio, ranked #628.

Jones Financial Companies first reported a position in ALNY in Q4 2022 and has held it in 8 quarters since. 784 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • Jones Financial Companies held 80,491 shares of Alnylam Pharmaceuticals worth $23.5M as of Q2 2026.
  • Jones Financial Companies bought 6,848 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $2.07M.
  • Alnylam Pharmaceuticals made up 0.01% of Jones Financial Companies's portfolio in Q2 2026, its #628 holding.
  • Jones Financial Companies first reported a position in Alnylam Pharmaceuticals in Q4 2022 and has held it in 8 quarters since.
  • 784 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.